Blog

The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial

Feb . 28 . 2019

Changes in skeletal muscle area and lean body mass during pazopanib vs sunitinib therapy for metastatic renal cancer

Feb . 28 . 2019

Personalised treatment benefits kidney cancer patients

Feb . 28 . 2019

Personalized Vaccine to be Tested in Patients with Kidney Cancer

Feb . 28 . 2019

First-Line TKIs Less Effective in Non-Clear-Cell Renal Cell Carcinoma

Feb . 28 . 2019

Imaging Advances in the Management of Kidney Cancer

Feb . 25 . 2019

Kidney Cancer Association Appoints Gretchen Vaughan as CEO

Feb . 24 . 2019

HOUSTON – January 24, 2019 – Kidney Cancer Association is pleased to announce it has recently appointed Gretchen Vaughan as the nonprofit’s new CEO. Vaughan brings more than 27 years of experience in advanced fundraising, management, sales and major market business development in the healthcare and financial service industries. Vaughan has most recently worked as the senior director of philanthropic…

Cutaneous metastasis of renal cell carcinoma: Fine needle aspiration provides rapid diagnosis

Feb . 23 . 2019

Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial

Feb . 23 . 2019

Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation

Feb . 23 . 2019

« Previous 1 … 53 54 55 56 57 Next »